Edward R. Fletcher
London, ENG SE11UL, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Animal models of Parkinson's disease: a guide to selecting the optimal model for your research.
Journal: Neuronal signaling
Published: October 10, 2021
Drug repurposing strategies of relevance for Parkinson's disease.
Journal: Pharmacology research & perspectives
Published: April 15, 2021
Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats.
Journal: Frontiers in neuroscience
Published: May 29, 2020
Diabetes in day case general and vascular surgery: A multicentre regional audit.
Journal: International journal of clinical practice
Published: November 23, 2019
Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
Journal: BMC neuroscience
Published: June 10, 2019
Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats.
Journal: Scientific reports
Published: January 29, 2019
Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner.
Journal: Neuropharmacology
Published: January 04, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026